Rosuvastatin Pre-Treatment Influences the Risk of Coronary Intervention Study

Summary

The aim of this study is to determine whether a pre-treatment with high-dose statin (one day prior and just before intervention, rosuvastatin 20mg/day) has a positive impact on the occurrence of periprocedural myocardial infarction during percutaneous coronary intervention (PCI).

Timeline

Start

2010-06

Primary completion

2012-06

Completion

2012-08

Drugs

Indications